It is estimated that in the United Kingdom (UK), the number of new business-to-consumer (B2C) policies in the private health insurance industry will have increased by approximately ************* policies between 2018 and 2024.Statista estimates that the share of new policies that will be taken out online between 2018 and 2024 will only grow marginally during this period. To learn more about the future of the B2C digital insurance industry in the UK, read our in-depth report.

The National Health Services (NHS) in the United Kingdom provides free universal coverage for all residents. Nevertheless, in 2022, **** percent of the population bought supplemental private insurance, this is mostly due to long waiting times in public care. This is the highest percentage reported since 2011, when a percentage of **** was also reported.

The UK Health Insurance Market size was valued at USD 281.8 billion in 2023 and is projected to reach USD 437.91 billion by 2032, exhibiting a CAGR of 6.5 % during the forecasts period. The market of health insurance in the United Kingdom refers to the consumption of policies in medical costs and service that aim to provide the customers with shields against costs of health care treatments. Such policies consist of private health insurance, which can get patients treatment faster and more unscheduled than the NHS, as well as having critical illness cover for monetary assistance in serious disease. They have become very popular in the individual as well as business disability market, and are usually sold with policies formulated according to different needs like basic, enhanced and most importantly inpatient. This is because the costs of health care continue to rise, there is awareness of health and wellness, as well as changes toconsumer buying patterns. Some trends are diversification of digital and telehealth care services, emergence of individual/personal health insurance, and pro- wellness/preventive care attributes.

Market Size and Growth: The UK health and medical insurance market is in a state of steady growth, with a projected CAGR of 4.56% from 2025 to 2033. The market size is estimated to be 8.17 million in 2025, with a value unit of millions. Key drivers behind this growth include rising healthcare costs, increased awareness of health and well-being, and the aging population. Trends and Segments: The market has witnessed several trends, including the growing popularity of private medical insurance, the emergence of healthcare cash plans, and the rise of dental insurance plans. The market is segmented based on product type (private medical insurance, healthcare cash plans, dental insurance plans) and procurement type (self-pay health coverage, employee-sponsored health coverage). Major players in the market include BUPA, AXA PPP, PT Astra Aviva Life, and Freedom Health Insurance. The report provides regional data for North America, South America, Europe, Middle East & Africa, and Asia Pacific. Publisher: [Market Research Company Name] Publish Date: [Month, Year] Number of Pages: [Number] Price: [Amount] The UK Health And Medical Insurance Market report presents a comprehensive analysis of the market including statistics, forecasts, competitive landscape, and trends. The report provides an in-depth look at the market's key segments, including product types, application, and end-user. The report also examines the market's major drivers and challenges and provides insights into the market's future prospects. Recent developments include: On November 2022, in partnership with online platform JAAQ in a six-month trial for boosting access to personalised expert-led health advice online. This adds to Bupa's mental health support which provides ongoing, around-the-clock support for a wealth of mental health conditions, such as anxiety, depression and addiction., On February 2022, AXA UK&I acquired renewable rights to Ageas UK's commercial business at an initial consideration of 47.5 million GBP. This acquisition will strengthen AXA's growth strategy and commitment to its commercial business customers and broker partnerships, particularly in the SME and Schemes market segments. As part of the agreement, around 100 Ageas UK employees will move to AXA Commercial to provide ongoing support and service delivery.. Notable trends are: Global Economic Slowdown and Better Government Insurance Services Affecting the United Kingdom Health and Medical Insurance.

Please provide the following information under FOI law full schedule of uk databases used to check eligibility for Health Insurance Card eg NI, passport, register of births number of applications for HI Card received april 22-april 23 number of applications rejected due to lack of proof of eligibility april 22-april 23 number of people required to provide further proof following application NHS definition of legal criteria for eligibility for Health Insurance Card Your request was received on 16 August 2023 and I am dealing with it under the terms of the Freedom of Information Act 2000. On 3 December 2023 you clarified the following: 1) When assessing UK Global Health Insurance Card applications does the Authority have access to UK Government records? For example Registration of Births, National Insurance, EU Settlement Scheme records, UK Passport Office Records, DVA Records of Driving Licences? 2) Please give me the number of applications for UK Global Health Insurance Card applications in the last financial year. Please also indicate the number that were approved and the number rejected due to insufficient proof of residency. On 27th December 2023 you clarified the following: 5) I can confirm I want the information for EHIC, UK EHIC and UK GHIC. Response Question 1 When assessing UK Global Health Insurance Card applications, the NHSBSA has access to some UK Government records, such as EU settlement Scheme records. The NHSBSA does not have access to National Insurance records, Registration of Births, UK Passport Office Records or DVA Records. UK Global Health Insurance Card applications are based on a residency system and the NHSBSA will use third party data provider Equifax to establish UK residency. This is stated in our Privacy Notice. https://www.nhsbsa.nhs.uk/our-policies/privacy/overseas-healthcare-services-privacy-notice#:~:text=You%20have%20the%20right%20to,it%20for%20longer%20than%20necessary Question 2 There were 6,510,849 UK Global Health Insurance Card applications in the last financial year. Question 3 and 4 6,016,310 applications were approved and 145,876 were rejected because we were unable to establish proof of residency. The remaining applications were either rejected for other reasons, or we have not yet finished dealing with them. Question 5 The following links provide definitions of legal criteria for eligibility for UK GHIC and UK EHIC: • https://faq.nhsbsa.nhs.uk/knowledgebase/article/KA-26813 • https://www.nhs.uk/using-the-nhs/healthcare-abroad/apply-for-a-free-uk-global-health-insurance-card-ghic/ Please note that we do not issue EHIC anymore as that card has been replaced by the UK EHIC.

The United Kingdom Health and Medical Insurance Market is Segmented by Policy Type (Individual Policies, Group/Corporate Policies), Coverage Type (In-Patient Only, Comprehensive, and More), Distribution Channel (IFAs, Direct-To-Consumer, Bancassurance & Affinity Partnerships, and More), End User (Individuals & Families, Smes, and More), and Region. The Market Forecasts are Provided in Value (USD).

Unlocking Data to Inform Public Health Policy and Practice: WP1 Mapping Review Supplementary Excel S1
The data extracted into Excel Tab "S1 Case studies (extracted)" represents information from 31 case studies as part of the "Unlocking Data to Inform Public Health Policy and Practice" project, Workpackage (WP) 1 Mapping Review. Details about the WP1 mapping review can be found in the "Unlocking Data to Inform Public Health Policy and Practice" project report, which can be found via this DOI link: https://doi.org/10.15131/shef.data.21221606

The Office for Health Improvement and Disparities (OHID) has published the Public Health Outcomes Framework (PHOF) quarterly data update for May 2022.

The data is presented in an interactive tool that allows users to view it in a user-friendly format. The data tool also provides links to further supporting information, to aid understanding of public health in a local population.

18 indicators have been updated in this release:

• healthy life expectancy and disability-free life expectancy at birth and at 65
• 7 indicators from the health improvement domain including conception rates in teenagers, percentage of looked after children whose emotional wellbeing is a cause for concern, and percentage of physically active adults
• 4 indicators from the health protection domain including the fraction of mortality attributable to particulate air pollution (new method), population vaccination coverage for human papillomavirus (HPV) vaccination coverage for two doses (females 13 to 14 years old) and population vaccination coverage - Meningococcal ACWY conjugate vaccine (MenACWY) (14 to 15 years)
• 5 indicators from the healthcare and premature mortality domain including emergency readmissions within 30 days of discharge from hospital and preventable sight loss

See links to indicators updated document for full details of what’s in this update.

View previous Public Health Outcomes Framework data tool updates.

Forecast: Healthcare Expenditure by Voluntary Health Insurance Schemes in the UK 2024 - 2028 Discover more data with ReportLinker!

Contemporary public health and healthcare are navigating a complex landscape marked by limited resources, conflicting individual and collective preferences, and the challenge of improving efficiency while maintaining quality. This scenario raises a multitude of ethical and moral questions, necessitating state intervention through stewardship and governance. Governments worldwide strive to enhance utility, value for money, and health equity, guided by principles of distributive and procedural justice. The moral underpinnings of public health activities, such as overall benefit, collective efficiency, distributive fairness, and harm prevention, are crucial in addressing global health resource challenges. These considerations encompass efficiency, equity, rights, and other ethical issues. The distribution of resources, whether based on noncorrelative or correlative principles, is a key aspect of justice in public health. Public health efforts are also focused on mitigating the adverse effects of socio-economic determinants on health outcomes and addressing health disparities. This is particularly vital for vulnerable, high-risk, and marginalized groups who face unique challenges like historic injustices, discrimination, and specific social or physical needs. The project at hand delves into the concepts outlined by Peragine, focusing on measuring individual opportunity sets, assessing inequality in opportunity distribution, and designing mechanisms to enhance 'opportunity equality'. A representative survey of Vienna's population (N=1411) explores various dimensions: Socio-demography: This module gathers data on gender, age, education, and migration background. Health: It assesses individual health status, chronic conditions, multimorbidity, and health-related behaviors. Socio-economic status: This includes occupation, net income, asset wealth, and other indicators of social or economic capital. Access to healthcare: Respondents provide insights into their experiences with healthcare access, including barriers and needs. Affordability of healthcare: Questions revolve around health-related expenditures and attitudes towards healthcare coverage and benefits. Provision of healthcare: This focuses on the quality and timeliness of medical interventions and healthcare services. Justice-Fairness attitudes: The survey captures attitudes towards social/distributive justice and fairness in socio-economic and health-related aspects. Preferences for health policy and redistribution: This module explores public vs. private health insurance preferences and allocation preferences for the public health budget. Solidarity & Reciprocity: Estimating solidarity through measures of social trust, cooperative behavior, sharing, helping, and expressions of solidarity. Overall, this comprehensive approach aims to address the intricate interplay of ethical, moral, and practical considerations in public health and healthcare, emphasizing the need for equitable and just solutions in a resource-constrained environment.

Businesses in this industry underwrite insurance policies relating to accidents and health. The premiums they earn from this are then invested to generate additional income. Underwriting life and disability insurance is not included in this industry, although operators may compete in both insurance markets.

Context

Mental Health Services Monthly Statistics

This publication provides the most timely picture available of people using NHS funded secondary mental health, learning disabilities and autism services in England. These are experimental statistics which are undergoing development and evaluation. This information will be of use to people needing access to information quickly for operational decision making and other purposes. More detailed information on the quality and completeness of these statistics is made available later in our Mental Health Bulletin: Annual Report publication series.

• COVID-19 and the production of statistics

Due to the coronavirus illness (COVID-19) disruption, it would seem that this is now starting to affect the quality and coverage of some of our statistics, such as an increase in non-submissions for some datasets. We are also starting to see some different patterns in the submitted data. For example, fewer patients are being referred to hospital and more appointments being carried out via phone/telemedicine/email. Therefore, data should be interpreted with care over the COVID-19 period.

Content

Time period covered Feb 1, 2020 - April 31, 2020

Area covered England

Acknowledgements

reference: Mental Health Services Monthly Statistics

Author: Community and Mental Health Team, NHS Digital
Responsible Statistician: Tom Poupart, Principal Information Analyst
Public Enquiries: Telephone: 0300 303 5678
Email: enquiries@nhsdigital.nhs.uk
Press enquiries should be made to: Media Relations Manager: Telephone: 0300 303 3888

Published by NHS Digital part of the Government Statistical Service Copyright © 2020 Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.

You may re-use this document/publication (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0.
To view this licence visit To view this licence visit www.nationalarchives.gov.uk/doc/open-government-licence www.nationalarchives.gov.uk/doc/open-government-licence or write to the Information Policy Team, The National Archives, or write to the Information Policy Team, The National Archives, Kew, Richmond, Surrey, TW9 4DU Kew, Richmond, Surrey, TW9 4DU; or email: psi@nationalarchives.gsi.gov.uk or email: psi@nationalarchives.gsi.gov.uk

Cover by-

Inspiration

This dataset is to solve the challenge- UNCOVER COVID-19 Challenge, United Network for COVID Data Exploration and Research. This data is scraped in hopes of solving the task - Mental health impact and support services.

Task Details Can we predict changes in demand for mental health services and how can we ensure access? (by region, social/economic/demographic factors, etc). Are there signs of shifts in mental health challenges across demographies, whether improvements or declines, as a result of COVID-19 and the various measures implement to contain the pandemic?

The UK health and medical insurance market, valued at approximately £8.17 billion in 2025, is projected to experience robust growth, driven by several key factors. Rising healthcare costs, coupled with an aging population and increasing prevalence of chronic diseases, are placing significant pressure on the National Health Service (NHS). This is leading to a surge in demand for private medical insurance (PMI) among individuals and employers seeking faster access to specialist care and shorter waiting times. The market is segmented by product type (Private Medical Insurance – individual and group policies; Healthcare Cash Plans; Dental Insurance Plans) and procurement type (self-pay and employer-sponsored). The growth of employer-sponsored health coverage reflects a trend among businesses to offer competitive benefits packages to attract and retain talent. Furthermore, technological advancements, such as telehealth and digital health platforms, are improving accessibility and efficiency within the sector, fueling further market expansion. Competitive pressures from established players like Bupa, AXA PPP, and Aviva, alongside the emergence of newer entrants, are fostering innovation and driving down costs in specific segments. However, market growth is not without its restraints. Regulatory changes, economic uncertainties, and concerns over affordability, particularly for individual policies, pose challenges to the market's expansion. The increasing cost of premiums, alongside concerns about policy exclusions and limitations, can impact consumer adoption. Despite these challenges, the long-term outlook for the UK health and medical insurance market remains positive. The projected Compound Annual Growth Rate (CAGR) of 4.56% suggests a considerable increase in market value over the forecast period (2025-2033). This growth is likely to be driven primarily by the continued demand for private healthcare solutions, supplemented by ongoing technological advancements and an evolving regulatory landscape that shapes both competition and consumer access. Recent developments include: On November 2022, in partnership with online platform JAAQ in a six-month trial for boosting access to personalised expert-led health advice online. This adds to Bupa's mental health support which provides ongoing, around-the-clock support for a wealth of mental health conditions, such as anxiety, depression and addiction., On February 2022, AXA UK&I acquired renewable rights to Ageas UK's commercial business at an initial consideration of 47.5 million GBP. This acquisition will strengthen AXA's growth strategy and commitment to its commercial business customers and broker partnerships, particularly in the SME and Schemes market segments. As part of the agreement, around 100 Ageas UK employees will move to AXA Commercial to provide ongoing support and service delivery.. Notable trends are: Global Economic Slowdown and Better Government Insurance Services Affecting the United Kingdom Health and Medical Insurance.

The NIHR is one of the main funders of public health research in the UK. Public health research falls within the remit of a range of NIHR Research Programmes, NIHR Centres of Excellence and Facilities, plus the NIHR Academy. NIHR awards from all NIHR Research Programmes and the NIHR Academy that were funded between January 2006 and the present extraction date are eligible for inclusion in this dataset. An agreed inclusion/exclusion criteria is used to categorise awards as public health awards (see below). Following inclusion in the dataset, public health awards are second level coded to one of the four Public Health Outcomes Framework domains. These domains are: (1) wider determinants (2) health improvement (3) health protection (4) healthcare and premature mortality.More information on the Public Health Outcomes Framework domains can be found here.This dataset is updated quarterly to include new NIHR awards categorised as public health awards. Please note that for those Public Health Research Programme projects showing an Award Budget of £0.00, the project is undertaken by an on-call team for example, PHIRST, Public Health Review Team, or Knowledge Mobilisation Team, as part of an ongoing programme of work.Inclusion criteriaThe NIHR Public Health Overview project team worked with colleagues across NIHR public health research to define the inclusion criteria for NIHR public health research awards. NIHR awards are categorised as public health awards if they are determined to be ‘investigations of interventions in, or studies of, populations that are anticipated to have an effect on health or on health inequity at a population level.’ This definition of public health is intentionally broad to capture the wide range of NIHR public health awards across prevention, health improvement, health protection, and healthcare services (both within and outside of NHS settings). This dataset does not reflect the NIHR’s total investment in public health research. The intention is to showcase a subset of the wider NIHR public health portfolio. This dataset includes NIHR awards categorised as public health awards from NIHR Research Programmes and the NIHR Academy. This dataset does not currently include public health awards or projects funded by any of the three NIHR Research Schools or any of the NIHR Centres of Excellence and Facilities. Therefore, awards from the NIHR Schools for Public Health, Primary Care and Social Care, NIHR Public Health Policy Research Unit and the NIHR Health Protection Research Units do not feature in this curated portfolio.DisclaimersUsers of this dataset should acknowledge the broad definition of public health that has been used to develop the inclusion criteria for this dataset. This caveat applies to all data within the dataset irrespective of the funding NIHR Research Programme or NIHR Academy award.Please note that this dataset is currently subject to a limited data quality review. We are working to improve our data collection methodologies. Please also note that some awards may also appear in other NIHR curated datasets. Further informationFurther information on the individual awards shown in the dataset can be found on the NIHR’s Funding & Awards website here. Further information on individual NIHR Research Programme’s decision making processes for funding health and social care research can be found here.Further information on NIHR’s investment in public health research can be found as follows: NIHR School for Public Health here. NIHR Public Health Policy Research Unit here. NIHR Health Protection Research Units here. NIHR Public Health Research Programme Health Determinants Research Collaborations (HDRC) here. NIHR Public Health Research Programme Public Health Intervention Responsive Studies Teams (PHIRST) here.

Bupa was the most popular health insurance provider among UK consumers in 2023, with ** percent of respondents liking the insurer. In comparison, WPA was the least popular health insurance provider in that year.

Forecast: Private Health Insurance Coverage in the UK 2024 - 2028 Discover more data with ReportLinker!

Forecast: Duplicate Private Health Insurance Coverage in the UK 2024 - 2028 Discover more data with ReportLinker!

The aims of this study were:
to explore how a sample of national health consumer groups represents the interests of patients, users and carers within the policy process through analysing their aims, objectives and strategies; examining their internal organisation and relationship with their members and grass-roots support; investigating how professional and business interests are incorporated and financial resources are mobilised.
to describe and analyse how these health consumer groups interact with central government departments and agencies, Parliament, and the media in relation to policy making.
to examine alliances between specific health consumer groups and investigate the particular role of umbrella consumer organisations in promoting alliances.
to assess the contribution of theoretical perspectives and models to an understanding of the role of health consumer groups and in particular to assess whether different strategies and modes of interaction are related to group characteristics.

IntroductionNon-medical prescribing was introduced into the United Kingdom (UK) to improve patient care, through extending healthcare professionals’ roles. More recent government health service policy focuses on the increased demand and the need for efficiency. This systematic policy review aimed to describe any changes in government policy position and the role that non-medical prescribing plays in healthcare provision.MethodThe systematic policy review included policy and consultation documents that describe independent non-medical prescribing. A pre-defined protocol was registered with PROSPERO (CRD42015019786). Professional body websites, other relevant websites and the following databases were searched to identify relevant documents: HMIC, Lexis Nexis, UK Government Web Archive, UKOP, UK Parliamentary Papers and Web of Science. Documents published between 2006 and February 2018 were included.Results and discussionFollowing exclusions, 45 documents were selected for review; 23 relating to policy or strategy and 22 to consultations. Of the former, 13/23 were published 2006–2010 and the remainder since 2013. Two main themes were identified: chronological aspects and healthcare provision. In the former, a publication gap for policy documents resulted from a change in government and associated major healthcare service reorganisation. In the later, the role of non-medical prescribing was found to have evolved to support efficient service delivery, and cost reduction. For many professions, prescribing appears embedded into practice; however, the pharmacy profession continues to produce policy documents, suggesting that prescribing is not yet perceived as normal practice.ConclusionPrescribing appears to be more easily adopted into practice where it can form part of the overall care of the patient. Where new roles are required to be established, then prescribing takes longer to be universally adopted. While this review concerns policy and practice in the UK, the aspect of role adoption has wider potential implications.